Delivery Order SPE2DR25D3303-SPE2DR26F64F0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count format) under a firm fixed-price contract valued at $11,572.48. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025, and is classified as a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three. This is a firm fixed-price delivery order with a ceiling value of $33,895.75 and an ultimate completion date of December 17, 2025. The award was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,776.11 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg oral disintegrating tablets in unit dose packaging. This non-competitive, firm fixed-price delivery order was executed on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,327.49 to AmerisourceBergen Drug Corp for Zolmitriptan 5 mg orally disintegrating tablets (ODT) in unit dose packages of three, with a firm fixed price and an ultimate completion date of December 18, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, valued at $1,613.03 with a firm fixed price structure, represents a single delivery order without set-aside designation. The contract is scheduled for completion on October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitively awarded, non-set-aside contract carries a ceiling value of $1,069.34 and is classified as a firm fixed price delivery order with an ultimate completion date of November 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $18,142.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg tablets in unit dose packages of 6, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,880.50 delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three on December 2, 2025. This non-set-aside, firm fixed-price contract is scheduled for completion by December 3, 2025, with performance at the awardee's corporate office in Conshohocken, Pennsylvania. Zolmitriptan is a triptan medication used in the treatment of migraine headaches, representing a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.90 to AmerisourceBergen Drug Corp for Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging of three units. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of December 12, 2025. The award was issued on December 11, 2025, and the pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F64F0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,257.26 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6 tablets). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and represents a non-set-aside procurement. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location of AmerisourceBergen Drug Corp, the nation's largest pharmaceutical distributor serving federal medical procurement needs. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a comprehensive portfolio of pharmaceutical products and medical supplies supporting military healthcare programs and other federal health systems worldwide, including the Defense Health Agency and U.S. Coast Guard. Zolmitriptan, a migraine treatment medication, represents one category of neurological therapeutics within AmerisourceBergen Drug Corp's extensive federal pharmaceutical portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/18/25 |